Search
Search
About
Log in
Join
Experiences with
Triple bromide
Posts
Communities
5,255 public posts
Filter results
Here's a $1000 paid online market research study, inviting mCRPC patients, spouses, partners, and caregivers
Here's a $1000 paid online market research study inviting patients, spouses, partners, and caregivers. This study will tap into your/your loved one's personal experience and story as metastatic castration resistant prostate cancer (mCRPC) patients or if you have neuroendocrine prostate cancer. This
Here's a $1000 paid online market research study inviting patients, spouses, partners, and caregivers. This study will tap into your/your loved one's personal experience and story as metastatic castration resistant prostate cancer (mCRPC) patients or if you have neuroendocrine prostate cancer. This
Darryl
Partner
in
Advanced Prostate Cancer
2 years ago
Israeli company to test if fecal bacteria pills boost cancer immunotherapy
Illustration of the human microbiome (Design Cells via iStock by Getty Images)
Israeli company to test if fecal bacteria pills boost cancer immunotherapy
Prospective medication seeks to tweak gut germs in patients who don’t respond well to treatment, utilizing research that suggests microbiome
Illustration of the human microbiome (Design Cells via iStock by Getty Images)
Israeli company to test if fecal bacteria pills boost cancer immunotherapy
Prospective medication seeks to tweak gut germs in patients who don’t respond well to treatment, utilizing research that suggests microbiome
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
2 years ago
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy
https://www.asiaone.com/business/alterity-therapeutics-announces-regulatory-authorization-proceed-ath434-phase-2-clinical-0 Alterity's lead candidate, ATH434, is the first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration
https://www.asiaone.com/business/alterity-therapeutics-announces-regulatory-authorization-proceed-ath434-phase-2-clinical-0 Alterity's lead candidate, ATH434, is the first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration
Hidden
in
Cure Parkinson's
2 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Testosterone “Flare” (Or Testosterone?) Timing to Optimize Salvage Radiation Therapy
I have referred to the following article a few times in response to some posts about the use and timing of ADT when used in addition (adjuvant) to improve outcomes from salvage radiation therapy for BCR for failure after primary prostate treatment (surgical or radiation or other). Also for recurrences
I have referred to the following article a few times in response to some posts about the use and timing of ADT when used in addition (adjuvant) to improve outcomes from salvage radiation therapy for BCR for failure after primary prostate treatment (surgical or radiation or other). Also for recurrences
MateoBeach
in
Advanced Prostate Cancer
2 years ago
Testosterone “Flare” (Or Testosterone?) Timing to Optimize Salvage Radiation Therapy
I have referred to the following article a few times in response to some posts about the use and timing of ADT when used in addition (adjuvant) to improve outcomes from salvage radiation therapy for BCR for failure after primary prostate treatment (surgical or radiation or other). Also for recurrences
I have referred to the following article a few times in response to some posts about the use and timing of ADT when used in addition (adjuvant) to improve outcomes from salvage radiation therapy for BCR for failure after primary prostate treatment (surgical or radiation or other). Also for recurrences
MateoBeach
in
Fight Prostate Cancer
2 years ago
Clinical trials invitation
Clinical trials invitation :Study title :IMID BIOResource(Immune mediated Inflammatory Diseases) I have been sent this invitation to participate via my Rheumatology Department. It comes from The National Institute for Health Research. Only too pleased to help after 50 years of RA. Lots of progress made
Clinical trials invitation :Study title :IMID BIOResource(Immune mediated Inflammatory Diseases) I have been sent this invitation to participate via my Rheumatology Department. It comes from The National Institute for Health Research. Only too pleased to help after 50 years of RA. Lots of progress made
tinlizzie
in
NRAS
2 years ago
Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
New clinical trial registered: Biogen and Denaliti have initiated the 2nd late-stage study of their LRRK2 inhibitor BIIB122; Phase 3, randomized, double-blind, placebo-controlled efficacy & safety study in 400 individuals with LRRK2-associated #Parkinsons https://clinicaltrials.gov/ct2/show/NCT05418673
New clinical trial registered: Biogen and Denaliti have initiated the 2nd late-stage study of their LRRK2 inhibitor BIIB122; Phase 3, randomized, double-blind, placebo-controlled efficacy & safety study in 400 individuals with LRRK2-associated #Parkinsons https://clinicaltrials.gov/ct2/show/NCT05418673
Hidden
in
Cure Parkinson's
2 years ago
New clinical trial registered: Inhibikase Therapeutics are initiating a Phase 2 study of their c-ABL inhibitor IkT-148009
New clinical trial registered: Inhibikase Therapeutics @inhibikase are initiating a Phase 2 study of their c-ABL inhibitor IkT-148009 in 120 individuals with untreated #Parkinsons; Safety & tolerability of 3 doses; 12-week study https://clinicaltrials.gov/ct2/show/NCT05424276 https://twitter.com/ScienceofPD
New clinical trial registered: Inhibikase Therapeutics @inhibikase are initiating a Phase 2 study of their c-ABL inhibitor IkT-148009 in 120 individuals with untreated #Parkinsons; Safety & tolerability of 3 doses; 12-week study https://clinicaltrials.gov/ct2/show/NCT05424276 https://twitter.com/ScienceofPD
Hidden
in
Cure Parkinson's
2 years ago
People of HU: A Family Affair - Obsessive-Compulsive Disorder
Today we are introducing you to Stephanie, a retired State Registered Nurse, who lives in Bradley Stroke, a town in South Gloucestershire, England. Stephanie gives us an insight into her life with OCD. She enjoys listening to classical music, doing online puzzles, and gardening, noting that she never
Today we are introducing you to Stephanie, a retired State Registered Nurse, who lives in Bradley Stroke, a town in South Gloucestershire, England. Stephanie gives us an insight into her life with OCD. She enjoys listening to classical music, doing online puzzles, and gardening, noting that she never
SaskiaHU
HealthUnlocked
in
HealthUnlocked Blog
2 years ago
When Children Get Liver Cancer live workshop
During this live workshop, you will learn about primary liver cancer aka hepatocellular carcinoma (HCC), its occurrence in children, and available treatment options, including immunotherapy and clinical trials. Sign up now: https://www.crowdcast.io/e/hcc-ped-workshop/
During this live workshop, you will learn about primary liver cancer aka hepatocellular carcinoma (HCC), its occurrence in children, and available treatment options, including immunotherapy and clinical trials. Sign up now: https://www.crowdcast.io/e/hcc-ped-workshop/
AndreaWilson_Founder
Caregiver
in
Blue Faery Liver Cancer
2 years ago
ABL301 (CNS penetrant bispecific a-syn antibody) is set to start Phase 1 clinical trials at the end of the year
The event that really changed ABL Bio’s global standing was a technology transfer deal worth around $1.06 billion that it inked with Paris-based health care company Sanofi in January for ABL301, a treatment candidate for degenerative brain diseases such as Parkinson’s disease that is currently undergoing
The event that really changed ABL Bio’s global standing was a technology transfer deal worth around $1.06 billion that it inked with Paris-based health care company Sanofi in January for ABL301, a treatment candidate for degenerative brain diseases such as Parkinson’s disease that is currently undergoing
Hidden
in
Cure Parkinson's
2 years ago
Parkinson’s
How do I apply for clinical trials in Parkinson’s
How do I apply for clinical trials in Parkinson’s
berniemyk
in
Cure Parkinson's
2 years ago
Clinical Trials
Can any of you who live in the UK help with these??? https://www.parkinsons.org.uk/news/save-parkinsons-clinical-research-take-part-today?utm_campaign=save-clinical&utm_source=twitter&utm_medium=organic&utm_content=parkinsons
Can any of you who live in the UK help with these??? https://www.parkinsons.org.uk/news/save-parkinsons-clinical-research-take-part-today?utm_campaign=save-clinical&utm_source=twitter&utm_medium=organic&utm_content=parkinsons
smv123
in
Cure Parkinson's
2 years ago
From Dr. Sperling
The word cure seems to be disappearing from talk about cancer. These days, doctors are more likely to talk about cancer control, rather than cure. This is partly because cancers that used to be a death sentence are now seen as a chronic disease that patients can live with for years, thanks to recent
The word cure seems to be disappearing from talk about cancer. These days, doctors are more likely to talk about cancer control, rather than cure. This is partly because cancers that used to be a death sentence are now seen as a chronic disease that patients can live with for years, thanks to recent
Fash01
in
Advanced Prostate Cancer
2 years ago
'Substandard' Control Arms in Clinical Trials– Practice found common in prostate cancer studies
https://www.medpagetoday.com/reading-room/asco/prostate-cancer/99141?xid=NL_ASCORR_2022-06-16&eun=g20939503d39r&pos= Several new anticancer drugs have been approved on the basis of clinical trials that used substandard control arms, and this problematic practice is continuing, noted authors of a recent
https://www.medpagetoday.com/reading-room/asco/prostate-cancer/99141?xid=NL_ASCORR_2022-06-16&eun=g20939503d39r&pos= Several new anticancer drugs have been approved on the basis of clinical trials that used substandard control arms, and this problematic practice is continuing, noted authors of a recent
GeorgeGlass
in
Advanced Prostate Cancer
2 years ago
Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care
[i]"A substantial number of anticancer drugs receive marketing authorization on the basis of data that do not prove their superiority over standard-of-care treatment because of the use of substandard control arms in clinical trials."[/i]
Many who read here make their treatment decisions based
[i]"A substantial number of anticancer drugs receive marketing authorization on the basis of data that do not prove their superiority over standard-of-care treatment because of the use of substandard control arms in clinical trials."[/i]
Many who read here make their treatment decisions based
cujoe
in
Fight Prostate Cancer
2 years ago
Exercise is Medicine
Just another reminder... For Prostate Cancer Survivors, Exercise is Medicine Christina Dieli-Conwright, PhD, MPH Harvard: Dana-Farber Cancer Institute What this means for patients: Dr. Dieli-Conwright has shown that exercise significantly benefits patients with prostate cancer, including improving
Just another reminder... For Prostate Cancer Survivors, Exercise is Medicine Christina Dieli-Conwright, PhD, MPH Harvard: Dana-Farber Cancer Institute What this means for patients: Dr. Dieli-Conwright has shown that exercise significantly benefits patients with prostate cancer, including improving
Scout4answers
in
Advanced Prostate Cancer
2 years ago
3.30pm Tues 5th July - webinar - What can help me when making decisions about joining clinical trials
Taking part in a clinical trial will be a consideration many of you will at some time undertake. The aim of this Leukaemia Care webinar is to help inform you of how clinical trials are run and elements you should consider when making decisions. The webinar and expert panel will seek to answer questions
Taking part in a clinical trial will be a consideration many of you will at some time undertake. The aim of this Leukaemia Care webinar is to help inform you of how clinical trials are run and elements you should consider when making decisions. The webinar and expert panel will seek to answer questions
HAIRBEAR_UK
in
Leukaemia Support
2 years ago
The article referred to below
This paper is behind a paywall, so I'll get it elsewhere. But it shows the benefits of giving T3 to patients after heart failure. This is just the abstract
Effects of Acute Triiodothyronine Treatment in Patients with Anterior Myocardial Infarction Undergoing Primary Angioplasty: Evidence from a Pilot
This paper is behind a paywall, so I'll get it elsewhere. But it shows the benefits of giving T3 to patients after heart failure. This is just the abstract
Effects of Acute Triiodothyronine Treatment in Patients with Anterior Myocardial Infarction Undergoing Primary Angioplasty: Evidence from a Pilot
diogenes
in
Thyroid UK
2 years ago
Clinical trial suggests Parkinson's drug is safe in humans
A new study finds an experimental drug that is significant for PD treatment " A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical
A new study finds an experimental drug that is significant for PD treatment " A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical
Abdiqani
in
Cure Parkinson's
2 years ago
1
...
54
55
56
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1311 results
Cure Parkinson's
658 results
CLL Support
628 results
View top 10 communities
Sort by
Most Relevant
Newest